Well written. The statements that were made have been misleading. All the way along. Mass Production, Shipping, and OTC regulation are all sending investors down the wrong path. But for me the worst one was the idea that they were in 5000+ stores. They were never in that many, and on top of that, as many posters pointed out, the product gets lost in those bulk stores. Without advertising, they were not going anywhere.
THe other kudos should go to all those who pointed out the form of the buds just didn't work aestically. They were too big, too ugly.
I wouldn't be counting on any of the management to be overally concerned if this trades again. Its a classic case of they have earnt their money through salary.
Cunnington leaves, luna leaves IR guy leaves.
- Forums
- ASX - By Stock
- NUH
- Ann: March 2024 Quarterly Appendix 4C
Ann: March 2024 Quarterly Appendix 4C, page-55
-
-
- There are more pages in this discussion • 212 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NUH (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.91M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NUH (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online